Arrowhead Pharmaceuticals Inc (ARWR)
EBITDA Margin
-196.25%
Quarterly · Period ending:
ARWR EBITDA Margin
Latest reported-196.25%period ending
Latest reported-196.25%period ending
ARWR Quarterly EBITDA Margin (-33.33% → -196.25%)
Quarterly ebitda margin
High-resolution chart · PNG
ARWR ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -470.6703% | |
| -25,005.2632% | |
| -634.8846% | |
| -310.8464% | |
| -437.1452% | |
| -355% | |
| -615.334% | |
| -800% | |
| 6,200% | |
| -300% | |
| -200% | |
| -200% | |
| -100% | |
| -33.3333% |